# Safety and Efficacy of Sustained Erythropoietin Therapy

> **NCT00542568** · PHASE1,PHASE2 · COMPLETED · sponsor: **Medgenics Medical Israel Ltd.** · enrollment: 19 (actual)

## Conditions studied

- Anemia

## Interventions

- **BIOLOGICAL:** EPODURE (dermal Biopump for erythropoietin)

## Key facts

- **NCT ID:** NCT00542568
- **Lead sponsor:** Medgenics Medical Israel Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2012-07
- **Final completion:** 2013-01
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2014-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00542568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00542568, "Safety and Efficacy of Sustained Erythropoietin Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00542568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*